Evidence map›Paper›PMID 25025377›Full record

ArticlePloS one2014

Processive DNA demethylation via DNA deaminase-induced lesion resolution.

Don-Marc Franchini, Chun-Fung Chan, Hugh Morgan, Elisabetta Incorvaia, Gopinath Rangam, Wendy Dean, Fatima Santos, Wolf Reik, Svend K Petersen-Mahrt

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Pathways of DNA Demethylation.Advances in experimental medicine and biology · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Don-Marc FranchiniDNA Editing in Immunity and Epigenetics, IFOM-Fondazione Instituto FIRC di Oncologia Molecolare, Milano, Italy; DNA Editing Lab, Clare Hall Laboratories, London Research Institute, South Mimms, United Kingdom.
Chun-Fung ChanLaboratory of Developmental Genetics and Imprinting, The Babraham Institute, Cambridge, United Kingdom.
Hugh MorganLaboratory of Developmental Genetics and Imprinting, The Babraham Institute, Cambridge, United Kingdom.
Elisabetta IncorvaiaDNA Editing in Immunity and Epigenetics, IFOM-Fondazione Instituto FIRC di Oncologia Molecolare, Milano, Italy.
Gopinath RangamDNA Editing in Immunity and Epigenetics, IFOM-Fondazione Instituto FIRC di Oncologia Molecolare, Milano, Italy; DNA Editing Lab, Clare Hall Laboratories, London Research Institute, South Mimms, United Kingdom.
Wendy DeanLaboratory of Developmental Genetics and Imprinting, The Babraham Institute, Cambridge, United Kingdom.
Fatima SantosLaboratory of Developmental Genetics and Imprinting, The Babraham Institute, Cambridge, United Kingdom.
Wolf ReikLaboratory of Developmental Genetics and Imprinting, The Babraham Institute, Cambridge, United Kingdom; Centre for Trophoblast Research, University of Cambridge, Cambridge, United Kingdom.
Svend K Petersen-MahrtDNA Editing in Immunity and Epigenetics, IFOM-Fondazione Instituto FIRC di Oncologia Molecolare, Milano, Italy; DNA Editing Lab, Clare Hall Laboratories, London Research Institute, South Mimms, United Kingdom.
Babraham Institute · GBFIRC Institute of Molecular Oncology · IT

Funding

Wellcome Trust 095645
6 · The paper itself

Abstract

Base modifications of cytosine are an important aspect of chromatin biology, as they can directly regulate gene expression, while DNA repair ensures that those modifications retain genome integrity. Here we characterize how cytosine DNA deaminase AID can initiate DNA demethylation. In vitro, AID initiated targeted DNA demethylation of methyl CpGs when in combination with DNA repair competent extracts. Mechanistically, this is achieved by inducing base alterations at or near methyl-cytosine, with the lesion being resolved either via single base substitution or a more efficient processive polymerase dependent repair. The biochemical findings are recapitulated in an in vivo transgenic targeting assay, and provide the genetic support of the molecular insight into DNA demethylation. This targeting approach supports the hypothesis that mCpG DNA demethylation can proceed via various pathways and mCpGs do not have to be targeted to be demethylated.

Indexed as

DNA DamageDNA MethylationAnimalsCpG IslandsCytidine DeaminaseMiceMice, TransgenicCytidine Deaminase

Identifiers

PMID25025377
PMCPMC4098905
OpenAlexW2047147520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.